Cara Therapeutics, Inc (CARA) Covered Calls

Cara Therapeutics, Inc covered calls Cara Therapeutics Inc is a clinical-stage biopharmaceutical company developing and commercializing new chemical entities designed to alleviate pain by selectively targeting kappa opioid receptors.

You can sell covered calls on Cara Therapeutics, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for CARA (prices last updated Mon 4:16 PM ET):

Cara Therapeutics, Inc (CARA) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
19.84 +0.47 19.00 19.86 448K - 0.8B
Covered Calls For Cara Therapeutics, Inc (CARA)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Jun 21 20 0.45 19.41 2.3% 168%
Jul 19 20 1.00 18.86 5.3% 58.6%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

CARA Therapeutics, Inc. is an emerging biotechnology company focused on developing novel therapeutics to treat human diseases associated with pain, inflammation and pruritus. The company involves in the developing of novel and proprietary class of product candidates that target the body's peripheral nervous system and have demonstrated efficacy in patients with moderate-to-severe pain without undesirable side effects typically associated with currently available pain therapeutics. Its product candidate includes I.V. CR845, Oral CR845 and CR701. CARA Therapeutics was founded by Derek T. Chalmers, Michael E. Lewis and Frédérique Menzaghi on July 2, 2004 and is headquartered in Shelton, CT.